COGNEX CORP (CGNX)
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CGNX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CGNX | Independent Director | 65 | ["Executive leadership experience: Held CFO role at fast-growing companies in the technology and healthcare industries, including organizations focused on digital communication platforms and biotechnology","Public company board experience: Has served for over ten years on various boards, including three public company boards, and in multiple roles on committees","Extensive knowledge of corporate finance, financial reporting, and institutional investing: Former CFO of public and private companies who co-led IPOs, follow-on offerings, and M&A transactions and gained deep capital markets and operations expertise; accomplished institutional investor in publicly traded securities"] | ["Audit (Chair)"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VC | Former Managing Director, Farallon Capital Management, LLC | 65 | ["Managing Director of Farallon Capital Management, LLC","Chief Financial Officer of eGroups, Inc.","Chief Financial Officer of Amylin Pharmaceuticals, Inc.","Experience as a member of the Board of Directors of Cognex Corporation","Public board experience","Extensive knowledge of corporate finance and financial reporting","Financial leadership in fast-growing companies in the technology and biotechnology sectors","Experience as an institutional investor"] | ["Audit Committee"] | 2026 |
| QNST | Director | 58 | [] | [] | 2018 |
Biography sourced from the proxy statement filing.
Former Managing Director, Farallon Capital Management, LLC Independent Director, 65 years old Director Since November 2021 Committee Membership Audit (Chair) Other Current & Previous Board Directorships Visteon Corporation (Nasdaq: VC) (Audit and Organization and Compensation Committees) since 2025; The diaTribe Foundation (Compensation Committee and Chair of Audit Committee) from 2017-2025; QuinStreet, Inc. (Nasdaq: QNST) (Audit Committee) from 2014-2018 Experience and Qualification Highlights Executive leadership experience: Held CFO role at fast-growing companies in the technology and healthcare industries, including organizations focused on digital communication platforms and biotechnology Public company board experience: Has served for over ten years on various boards, including three public company boards, and in multiple roles on committees Extensive knowledge of corporate finance, financial reporting, and institutional investing: Former CFO of public and private companies who co-led IPOs, follow-on offerings, and M&A transactions and gained deep capital markets and operations expertise; accomplished institutional investor in publicly traded securities Career Highlights Farallon Capital Management, LLC Managing Director (2004-2009) Senior Research Analyst (2002-2003) Consultant (2001) eGroups, Inc. (acquired by Yahoo!) CFO (1999-2000) Amylin Pharmaceuticals, Inc. (previously Nasdaq: AMLN; acquired by Bristol Myers Squibb and AstraZeneca) CFO (1989-1998) Other Professional Experience and Community Involvement Highlights Named one of 20 Women in Finance You Should Add to Your Company s Board by Business Insider Served as a Trustee for Stanford University s Graduate School of Business Trust from 2008-2011 Education B.A. from Vanderbilt University M.B.A. from Stanford University s Graduate School of Business